← FDA Drug Approvals (Drugs@FDA)

NORETHIN 1/35E-21

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON PHARMS TEVA · Approved 1988-04-12

Drug application

FDA Application #

ANDA071480

Application type

Abbreviated New Drug Application (Generic)

Brand name

NORETHIN 1/35E-21

Generic name

Ethinyl Estradiol

Active ingredients

ETHINYL ESTRADIOL; NORETHINDRONE

Dosage form

TABLET

Route

ORAL-21

Marketing status

Discontinued

Sponsor

WATSON PHARMS TEVA

First approval

1988-04-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown